CYTH(CYTH)
CYTH
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $29M | $57M | $117M |
| Low | $29M | $57M | $117M |
| High | $29M | $57M | $117M |
| EBITDA Avg | $-29M | $-57M | $-117M |
| Low | $-29M | $-57M | $-117M |
| High | $-29M | $-57M | $-117M |
| EBIT Avg | $-29M | $-57M | $-117M |
| Low | $-29M | $-57M | $-117M |
| High | $-29M | $-57M | $-117M |
| Net Income Avg | $-2M | $6M | $21M |
| Low | $-2M | $6M | $21M |
| High | $-2M | $6M | $21M |
| EPS Avg | $-0.13 | $0.35 | $1.28 |
| Low | $-0.13 | $0.35 | $1.28 |
| High | $-0.13 | $0.35 | $1.28 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |